Shandong Shengli Bioengineering

Shandong Shengli Bioengineering is a prominent Chinese pharmaceutical company specializing in the development and manufacture of veterinary drugs and animal health products. As a core subsidiary of China National Animal Health (CNAH) within the Sinopharm Group, the company operates one of the largest fermentation-based production bases for animal antibiotics in China. Their product portfolio includes high-quality APIs and finished dosages such as Tiamulin, Monensin, and Salinomycin, which are distributed globally. The company maintains rigorous quality standards with multiple GMP certifications and focuses on providing solutions for livestock disease prevention and growth promotion. Shandong Shengli Bioengineering is recognized for its advanced fermentation technology and its role in the international animal health supply chain.